Mode
Text Size
Log in / Sign up
N/A Completed N=36 Randomized Treatment

Exercise in Obese Diabetic Patients With Chronic Kidney Disease

Source: ClinicalTrials.gov NCT01036490 ↗
Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Apr 2016
Primary outcomePrimary: Change in Proteinuria — -34; -133 mg/g creatinine — p=0.04

Summary

Patients with type 2 diabetes, obesity, and chronic kidney disease are generally physically inactive, have a high mortality rate, and may benefit from an exercise program. This study seeks to determine if a structured exercise program will benefit the heart (improved exercise tolerance, decreased blood pressure) and/or the kidney (decreased protein loss in urine and stabilization of kidney function) and lead to improvements in diabetes, body composition, and quality of life.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Proteinuria
15; -66 0.39
SECONDARY
Change in Albuminuria
-13; -31
SECONDARY
Change in Estimated Glomerular Filtration Rate (eGFR)
-2.0; -3.1 0.58

Eligibility Criteria

Inclusion Criteria

  • Diabetes mellitus
  • CKD Stages 2-4
  • BMI > 30
  • Persistent proteinuria (urine protein/creatinine > 200 mg/g for > 3 mo)
  • On treatment with ACE inhibitor or ARB
  • On treatment with aspirin
  • On treatment with statin (if LDL > 100)

Exclusion Criteria

  • Symptomatic neuropathy/retinopathy
  • Positive stress test due to coronary arterial disease
  • Symptomatic cardiovascular disease
  • Congestive heart failure (New York Heart Association Class III or IV)
  • Chronic obstructive pulmonary disease (FEV1 < 50% predicted and/or requires supplemental oxygen support during exercise)
  • Complaints of angina during the stress test
  • Cerebrovascular disease/cognitive impairment
  • Renal transplant
  • Inability to walk on the treadmill
  • Any unforeseen illness or disability that would preclude exercise testing or training
  • Participation in a formal exercise program within the previous 12 weeks
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01036490). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search